![Prostate-specific antigen and prostate cancer: prediction, detection and monitoring | Nature Reviews Cancer Prostate-specific antigen and prostate cancer: prediction, detection and monitoring | Nature Reviews Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrc2351/MediaObjects/41568_2008_Article_BFnrc2351_Fig1_HTML.jpg)
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring | Nature Reviews Cancer
![Multiphasic 68Ga-PSMA PET/CT in the Detection of Early Recurrence in Prostate Cancer Patients with a PSA Level of Less Than 1 ng/mL: A Prospective Study of 135 Patients | Journal of Nuclear Multiphasic 68Ga-PSMA PET/CT in the Detection of Early Recurrence in Prostate Cancer Patients with a PSA Level of Less Than 1 ng/mL: A Prospective Study of 135 Patients | Journal of Nuclear](https://jnm.snmjournals.org/content/jnumed/61/10/1484/F1.large.jpg)
Multiphasic 68Ga-PSMA PET/CT in the Detection of Early Recurrence in Prostate Cancer Patients with a PSA Level of Less Than 1 ng/mL: A Prospective Study of 135 Patients | Journal of Nuclear
![a Bar chart demonstrating subgroup levels of PSA of 0.20–0.49 ng/mL,... | Download Scientific Diagram a Bar chart demonstrating subgroup levels of PSA of 0.20–0.49 ng/mL,... | Download Scientific Diagram](https://www.researchgate.net/publication/344247321/figure/fig4/AS:962708862169089@1606539087352/a-Bar-chart-demonstrating-subgroup-levels-of-PSA-of-020-049ng-mL-050-099ng-mL.png)
a Bar chart demonstrating subgroup levels of PSA of 0.20–0.49 ng/mL,... | Download Scientific Diagram
![68 Ga]Ga-PSMA PET/MRI images obtained in a 63-year-old man, PSA 0.50... | Download Scientific Diagram 68 Ga]Ga-PSMA PET/MRI images obtained in a 63-year-old man, PSA 0.50... | Download Scientific Diagram](https://www.researchgate.net/publication/347677951/figure/fig1/AS:992991300833284@1613758983785/68-GaGa-PSMA-PET-MRI-images-obtained-in-a-63-year-old-man-PSA-050-ng-mL-a-68.png)
68 Ga]Ga-PSMA PET/MRI images obtained in a 63-year-old man, PSA 0.50... | Download Scientific Diagram
![Combined MRI and PSA Strategy Improves Biopsy Decisions Compared with PSA Only: Longitudinal Observations of a Cohort of Patients with a PSA Level Less Than 20 ng/mL - Academic Radiology Combined MRI and PSA Strategy Improves Biopsy Decisions Compared with PSA Only: Longitudinal Observations of a Cohort of Patients with a PSA Level Less Than 20 ng/mL - Academic Radiology](https://www.academicradiology.org/cms/asset/7697bada-e963-4793-8311-cc9b0723a843/gr2.jpg)
Combined MRI and PSA Strategy Improves Biopsy Decisions Compared with PSA Only: Longitudinal Observations of a Cohort of Patients with a PSA Level Less Than 20 ng/mL - Academic Radiology
![Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer - ScienceDirect Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2287888215300118-gr1.jpg)
Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer - ScienceDirect
![3M (668X) Diamond Lapping Film 668X, 0.50 Micron PSA Disc, 4 in x NH: Amazon.com: Tools & Home Improvement 3M (668X) Diamond Lapping Film 668X, 0.50 Micron PSA Disc, 4 in x NH: Amazon.com: Tools & Home Improvement](https://m.media-amazon.com/images/I/21awVB9p9eL._AC_UF1000,1000_QL80_.jpg)
3M (668X) Diamond Lapping Film 668X, 0.50 Micron PSA Disc, 4 in x NH: Amazon.com: Tools & Home Improvement
![A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases | Journal of Translational Medicine | Full Text A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1479-5876-9-43/MediaObjects/12967_2011_Article_716_Fig4_HTML.jpg)
A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases | Journal of Translational Medicine | Full Text
![Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/fbc9fb93-c826-43a7-b92a-ac0d1359335c/gr1_lrg.jpg)
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine
![Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels | Prostate Cancer and Prostatic Diseases Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.pcan.4500957/MediaObjects/41391_2007_Article_BF4500957_Fig1_HTML.jpg)
Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels | Prostate Cancer and Prostatic Diseases
![Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel | Journal of Clinical Oncology Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2018/jco.2018.36.issue-4/jco.2017.75.3921/20180117/images/large/jco.2017.75.3921t4.jpeg)